SCHEMBL18130855

SCHEMBL18130855

CCOC(=O)Oc1ccc(C)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.55
L3MBTL1 Q9Y468 4/20 0.47
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 1/20 0.47
CTNNB1 P35222 2/20 0.46
WNT3A P56704 2/20 0.46
MAPT P10636 3/20 0.46
HTT P42858 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 2/20 0.46
ABL1 P00519 1/20 0.46
RIN1 Q13671 1/20 0.46
NPSR1 Q6W5P4 2/20 0.45
HSP90AA1 P07900 1/20 0.45
HPGD P15428 2/20 0.44
POLB P06746 2/20 0.44
CYP2C19 P33261 2/20 0.44
TSHR P16473 1/20 0.44
MEN1 O00255 1/20 0.44
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29852164 1.00 ACHE (0.55) ACHEL3MBTL1ALDH1A1KDM4ECTNNB1
Bicarbonate SCHEMBL28469716 0.97 ACHE (0.52) ACHEL3MBTL1ALDH1A1KDM4ECTNNB1
SCHEMBL14363150 0.91 CYP1A2 (0.46) ACHEALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL28879153 0.88 ACHE (0.65) ACHEL3MBTL1ALDH1A1CTNNB1WNT3A
SCHEMBL30474574 0.84 ACHE (0.61) ACHEL3MBTL1ALDH1A1KDM4ECTNNB1
SCHEMBL2565359 0.84 ACHE (0.61) ACHEL3MBTL1ALDH1A1KDM4ECTNNB1
SCHEMBL28469718 0.84 ACHE (0.52) ACHEL3MBTL1ALDH1A1KDM4ECTNNB1
SCHEMBL10961835 0.83 L3MBTL1 (0.48) ACHEL3MBTL1ALDH1A1KDM4ECTNNB1
SCHEMBL1598817 0.83 SMN1; SMN2 (0.51) L3MBTL1ALDH1A1KDM4EMAPTHTT
SCHEMBL6889856 0.83 TSHR (0.50) ACHEMAPTHTTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12616948-B2 Polyamide microcapsules FIRMENICH SA (CH) 2026-05-05 US disclosed
WO-2026087780-A1 CORE-SHELL MICROCAPSULES FIRMENICH SA (CH) 2026-04-30 WO disclosed
EP-4090453-B1 MICROCAPSULES COATED WITH A POLYSUCCINIMIDE DERIVATIVE FIRMENICH & CIE (CH) 2026-04-29 EP disclosed
EP-3280525-B2 PROCESS FOR PREPARING POLYUREA MICROCAPSULES FIRMENICH & CIE (CH) 2026-03-25 EP disclosed
EP-4711037-A2 PERFUME FORMULATION FOR DELIVERY SYSTEM Firmenich SA (CH) 2026-03-18 EP disclosed
EP-4711438-A2 PERFUME DELIVERY SYSTEM Firmenich SA (CH) 2026-03-18 EP disclosed
EP-4706627-A2 LAUNDRY COMPOSITION Firmenich SA (CH) 2026-03-11 EP disclosed
US-12569821-B2 Microcapsules coated with a polysuccinimide derivative FIRMENICH SA (CH) 2026-03-10 US disclosed
EP-4077625-B1 PERFUME DELIVERY SYSTEM FIRMENICH & CIE (CH) 2026-02-11 EP disclosed
EP-4077624-B1 PERFUME FORMULATION FOR DELIVERY SYSTEM FIRMENICH & CIE (CH) 2026-02-11 EP disclosed
WO-2019243426-A1 PROCESS FOR PREPARING MICROCAPSULES FIRMENICH SA (CH) 2019-12-26 WO disclosed
WO-2019243427-A1 PROCESS FOR PREPARING MINERALIZED MICROCAPSULES FIRMENICH SA (CH) 2019-12-26 WO disclosed
US-10385290-B2 Process for preparing polyurea microcapsules FIRMENICH SA (CH) 2019-08-20 US disclosed
EP-3280525-B1 PROCESS FOR PREPARING POLYUREA MICROCAPSULES FIRMENICH & CIE (CH) 2019-07-10 EP disclosed
US-20180112152-A1 PROCESS FOR PREPARING POLYUREA MICROCAPSULES FIRMENICH SA (CH) 2018-04-26 US disclosed
EP-3302404-A1 MICROCAPSULES WITH HIGH DEPOSITION ON SURFACES Firmenich SA (CH) 2018-04-11 EP disclosed
US-20180078468-A1 MICROCAPSULES WITH HIGH DEPOSITION ON SURFACES FIRMENICH SA (CH) 2018-03-22 US disclosed
EP-3280525-A1 PROCESS FOR PREPARING POLYUREA MICROCAPSULES Firmenich SA (CH) 2018-02-14 EP disclosed
WO-2016193435-A1 MICROCAPSULES WITH HIGH DEPOSITION ON SURFACES FIRMENICH SA (CH) 2016-12-08 WO disclosed
WO-2016162381-A1 PROCESS FOR PREPARING POLYUREA MICROCAPSULES FIRMENICH SA (CH) 2016-10-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12569821-B2 Microcapsules coated with a polysuccinimide derivative PAM, ACMSD, PFAS ACHE 2404/4885L3MBTL1 3474/4885ALDH1A1 2747/4885
US-12616948-B2 Polyamide microcapsules HDHD5, DDC, USP39 ACHE 2730/4885L3MBTL1 2993/4885ALDH1A1 4007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.